A carregar...
Phase II Randomized Study of Enzastaurin (LY317615) for Lung Cancer Prevention in Former Smokers
BACKGROUND: Chemoprevention for lung cancer with neutraceuticals or anti-inflammatory agents has had mixed clinical benefit. Novel targeted agents hold the promise of greater efficacy and selectivity. Here, we evaluated enzastaurin, a selective PKC-β inhibitor with antiproliferative and proapoptotic...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3578040/ https://ncbi.nlm.nih.gov/pubmed/23065656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.27836 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|